Found 240 resultsAuthor [ Title] Type Year
Filters: First Letter Of Title is C [Clear All Filters]
“A Crossover Design for Comparative Efficacy: A 36-Week Randomized Trial of Bevacizumab and Ranibizumab for Diabetic Macular Edema”, Ophthalmology, vol. 123, no. 4, p. 841, 2016.,
“Cross-Reactive Antibody Responses to Novel H5Nx Influenza Viruses Following Homologous and Heterologous Prime-Boost Vaccination with a Prepandemic Stockpiled A(H5N1) Vaccine in Humans”, J Infect Dis, vol. 216, no. suppl_4, pp. S555-S559, 2017.,
“Cross-sectional Analysis of Health Related Quality of Life in Pediatric Liver Transplant Recipients”, J Pediatr, vol. 156, no. 2, pp. 270-276.e271, 2010.,
“A Cross-Sectional Study in Eastern and Southern Africa to Characterize Laboratory Reference Intervals in Healthy Adults for HIV Prevention Trials”, in AIDS Vaccine 2008 Conference, Cape Town, South Africa, 2008.
“Cryopreservation-Related Loss of Antigen-Specific IFNγ Producing CD4(+) T-cells Can Skew Immunogenicity Data in Vaccine Trials: Lessons from a Malaria Vaccine Trial Substudy”, Vaccine, vol. 35, no. 15, pp. 1898-1906, 2017.,
“Current Concepts. Continuous Ambulatory Peritoneal Dialysis”, N Engl J Med, vol. 318, no. 24, pp. 1595-1600, 1988.,
“Current Cooperative Group Phase III Clinical Trials in Early Stage Breast Cancer”, Oncology, vol. 15, no. 2, pp. 176-7, 181-2, 185, 2001.,
“Current Status and Future Directions of Clinical Trials in Chronic Lymphocytic Leukemia”, Oncology (Williston Park), vol. 1, no. 8, pp. 31-40, 44, 1987.,
“The Current Understanding of the Endocrine Effects From Immune Checkpoint Inhibitors and Recommendations for Management.”, JNCI Cancer Spectr, vol. 2, no. 3, p. pky021, 2018.,
“Cyclophosphamide and Fluorouracil Combined with Mitoxantrone Versus Doxorubicin for Breast Cancer: Superiority of Doxorubicin”, J Clin Oncol, vol. 15, no. 5, pp. 1897-1905, 1997.,
“Cyclosporine to tacrolimus: effect on hypertension and lipid profiles in renal allografts”, Transplant Proc, vol. 30, pp. 1254-6, 1998.,
“Cytokine profiles in seronegative volunteers immunized with a recombinant canarypox and gp120 prime-boost HIV-1 vaccine. NIAID AIDS Vaccine Evaluation Group”, AIDS Res HumRetroviruses, vol. 14, pp. 1365-74, 2000.
“Cytomegalovirus infections following renal transplantation-effects of antiviral prophylaxis: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS),”, Pediatr Nephro., vol. 11, pp. 665-71, 1997.,
“Cytotoxic T cell and neutralizing antibody responses to human immunodeficiency virus type1 envelope with a combination vaccine regimen”, J Infec Dis, vol. 177, pp. 301-9, 1998.,